http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109836385-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-60 |
filingDate | 2019-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109836385-B |
titleOfInvention | Tetrahydroquinoline N-oxidation derivatives and preparation method and application thereof |
abstract | The present invention relates to tetrahydroquinoline N-oxide derivatives and a preparation method and application thereof. Specifically, it relates to the compound represented by the general formula (I), its preparation method and the pharmaceutical composition containing the compound, and its use as a BRD4 inhibitor in the treatment of cancer, inflammation, chronic liver disease, diabetes, cardiovascular disease, AIDS and other related diseases disease use. |
priorityDate | 2019-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 145.